Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,accountsPayable,changeToLiabilities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,changeToAccountReceivables,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,marketState,currency,exchange,shortName,market,priceHint,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry,address2
t0,EWOOF,267715.0,68886000,,,-191559,,-191559,251585,80281,-197552,-197552,,,,,,0,199249,396801,118968,5993,,-191559,-191559,616814.0,267715.0,6551.0,884529.0,4687376.0,-4429175.0,1.0,9514.0,104247.0,113608.0,573602.0,9514.0,623332.0,156950.0,5410.0,43211.0,544953.0,106607,20000,20000,16041,-9048,-29048,26248,4349,9266,-416652.0,en-US,US,EQUITY,False,Delayed Quote,REGULAR,USD,PNK,EASTWOOD BIO-MED CDA INC,us_market,4,Other OTC,Eastwood Bio-Medical Canada Inc.,CAD,17,16,0.120900035,0.10990912,1.1 - 1.62359,-0.40268993,-0.2480244,1.1,1.62359,1617101940,1625050740,1625659200,-0.009,0,0.004,1.3019453,-0.08104527,-0.062249366,1.4272093,-0.2063092,-0.14455427,91391816,305.225,15,America/New_York,EDT,-14400000,False,False,0.0,1.2209 - 1.2209,1.2209,0.0,0.0,0,0,finmb_144739250,1.2209,1630353263,0.0,1.2209,1.2209,1.2209,133,0.17,,,1.6236,1.1,1.3019,1.4272,17,16,68.89M,,20.98M,69.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Oct 30, 2020","Jan 30, 2021",-102.46%,-115.73%,-48.68%,-119.82%,780.8k,0.01,45.70%,213.31k,-857.8k,-800.05k,-0.0090,,113.61k,0,43.21k,16.14,0.27,0.00,-415.74k,-148.49k,Value,V6X 3Z6,Healthcare,"Eastwood Bio-Medical Canada Inc. distributes natural health supplements under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin and related products. Its products provide natural sourced solutions for metabolic syndromes, such as blood glucose disorders, obesity, and hypertension. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was incorporated in 2010 and is headquartered in Richmond, Canada.",Richmond,604 247 2100,BC,1609372800,Canada,http://www.eleotin.ca,86400,4871 Shell Road,604 247 2101,Biotechnology,Unit 1130
t-1,EWOOF,459274.0,68886000,,,-276254,,-276254,379862,45488,-405618,-405618,,-2307.0,,,,0,203039,608657,157551,129364,,-276254,-276254,474104.0,459274.0,7014.0,933378.0,4687376.0,-4237616.0,,9514.0,111196.0,122656.0,450893.0,9514.0,649580.0,172602.0,9698.0,23211.0,429437.0,-23934,20000,20000,245576,14525,14525,71244,50225,-52332,-278291.0,en-US,US,EQUITY,False,Delayed Quote,REGULAR,USD,PNK,EASTWOOD BIO-MED CDA INC,us_market,4,Other OTC,Eastwood Bio-Medical Canada Inc.,CAD,17,16,0.120900035,0.10990912,1.1 - 1.62359,-0.40268993,-0.2480244,1.1,1.62359,1617101940,1625050740,1625659200,-0.009,0,0.004,1.3019453,-0.08104527,-0.062249366,1.4272093,-0.2063092,-0.14455427,91391816,305.225,15,America/New_York,EDT,-14400000,False,False,0.0,1.2209 - 1.2209,1.2209,0.0,0.0,0,0,finmb_144739250,1.2209,1630353263,0.0,1.2209,1.2209,1.2209,133,0.17,,,1.6236,1.1,1.3019,1.4272,17,16,68.89M,,20.98M,69.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Oct 30, 2020","Jan 30, 2021",-102.46%,-115.73%,-48.68%,-119.82%,780.8k,0.01,45.70%,213.31k,-857.8k,-800.05k,-0.0090,,113.61k,0,43.21k,16.14,0.27,0.00,-415.74k,-148.49k,Value,V6X 3Z6,Healthcare,"Eastwood Bio-Medical Canada Inc. distributes natural health supplements under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin and related products. Its products provide natural sourced solutions for metabolic syndromes, such as blood glucose disorders, obesity, and hypertension. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was incorporated in 2010 and is headquartered in Richmond, Canada.",Richmond,604 247 2100,BC,1609372800,Canada,http://www.eleotin.ca,86400,4871 Shell Road,604 247 2101,Biotechnology,Unit 1130
t-2,EWOOF,735528.0,68886000,,,-73381,,-73381,102145,58486,-55159,-55159,,-2307.0,,,,0,184854,240013,126368,-18222,,-73381,-73381,265282.0,735528.0,17365.0,1000810.0,4687376.0,-3961362.0,,9514.0,387241.0,108131.0,225282.0,9514.0,422100.0,191469.0,59136.0,40000.0,207917.0,24816,20000,20000,-79813,-79228,-99228,11500,-6554,24203,-33813.0,en-US,US,EQUITY,False,Delayed Quote,REGULAR,USD,PNK,EASTWOOD BIO-MED CDA INC,us_market,4,Other OTC,Eastwood Bio-Medical Canada Inc.,CAD,17,16,0.120900035,0.10990912,1.1 - 1.62359,-0.40268993,-0.2480244,1.1,1.62359,1617101940,1625050740,1625659200,-0.009,0,0.004,1.3019453,-0.08104527,-0.062249366,1.4272093,-0.2063092,-0.14455427,91391816,305.225,15,America/New_York,EDT,-14400000,False,False,0.0,1.2209 - 1.2209,1.2209,0.0,0.0,0,0,finmb_144739250,1.2209,1630353263,0.0,1.2209,1.2209,1.2209,133,0.17,,,1.6236,1.1,1.3019,1.4272,17,16,68.89M,,20.98M,69.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Oct 30, 2020","Jan 30, 2021",-102.46%,-115.73%,-48.68%,-119.82%,780.8k,0.01,45.70%,213.31k,-857.8k,-800.05k,-0.0090,,113.61k,0,43.21k,16.14,0.27,0.00,-415.74k,-148.49k,Value,V6X 3Z6,Healthcare,"Eastwood Bio-Medical Canada Inc. distributes natural health supplements under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin and related products. Its products provide natural sourced solutions for metabolic syndromes, such as blood glucose disorders, obesity, and hypertension. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was incorporated in 2010 and is headquartered in Richmond, Canada.",Richmond,604 247 2100,BC,1609372800,Canada,http://www.eleotin.ca,86400,4871 Shell Road,604 247 2101,Biotechnology,Unit 1130
t-3,EWOOF,808908.0,68886000,,,-258857,,-258857,282873,49096,-245277,-245277,,-2307.0,,,,0,193662,438939,144566,-13580,,-258857,-258857,303464.0,808908.0,15258.0,1112372.0,4687376.0,-3887982.0,,9514.0,387241.0,187359.0,283464.0,9514.0,433600.0,291531.0,52584.0,20000.0,268206.0,-47349,20000,20000,-37391,-281989,-301989,11500,5908,24202,8067.0,en-US,US,EQUITY,False,Delayed Quote,REGULAR,USD,PNK,EASTWOOD BIO-MED CDA INC,us_market,4,Other OTC,Eastwood Bio-Medical Canada Inc.,CAD,17,16,0.120900035,0.10990912,1.1 - 1.62359,-0.40268993,-0.2480244,1.1,1.62359,1617101940,1625050740,1625659200,-0.009,0,0.004,1.3019453,-0.08104527,-0.062249366,1.4272093,-0.2063092,-0.14455427,91391816,305.225,15,America/New_York,EDT,-14400000,False,False,0.0,1.2209 - 1.2209,1.2209,0.0,0.0,0,0,finmb_144739250,1.2209,1630353263,0.0,1.2209,1.2209,1.2209,133,0.17,,,1.6236,1.1,1.3019,1.4272,17,16,68.89M,,20.98M,69.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Oct 30, 2020","Jan 30, 2021",-102.46%,-115.73%,-48.68%,-119.82%,780.8k,0.01,45.70%,213.31k,-857.8k,-800.05k,-0.0090,,113.61k,0,43.21k,16.14,0.27,0.00,-415.74k,-148.49k,Value,V6X 3Z6,Healthcare,"Eastwood Bio-Medical Canada Inc. distributes natural health supplements under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin and related products. Its products provide natural sourced solutions for metabolic syndromes, such as blood glucose disorders, obesity, and hypertension. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. Eastwood Bio-Medical Canada Inc. was incorporated in 2010 and is headquartered in Richmond, Canada.",Richmond,604 247 2100,BC,1609372800,Canada,http://www.eleotin.ca,86400,4871 Shell Road,604 247 2101,Biotechnology,Unit 1130
